154 related articles for article (PubMed ID: 34593478)
1. Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor.
Oda E; Yamamura K; Hara Y; Matsumura K; Akahoshi S; Yuki H; Motohara T; Miyamoto H; Kinoshita K; Matsumura F; Ohnishi K; Komohara Y; Beppu T
Anticancer Res; 2021 Oct; 41(10):5249-5254. PubMed ID: 34593478
[TBL] [Abstract][Full Text] [Related]
2. Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions.
Wen KW; Rabinovitch PS; Wang D; Mattis AN; Ferrell LD; Choi WT
Virchows Arch; 2020 Oct; 477(4):527-534. PubMed ID: 32296928
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E mutation in biliary proliferations associated with α
Angkathunyakul N; Rosini F; Heaton N; Foskett P; Quaglia A
Histopathology; 2017 Feb; 70(3):485-491. PubMed ID: 27627051
[TBL] [Abstract][Full Text] [Related]
4. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA
J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014
[TBL] [Abstract][Full Text] [Related]
5. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
6. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver.
Tajima T; Honda H; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Taguchi K; Shimada M; Masuda K
J Comput Assist Tomogr; 1999; 23(5):690-5. PubMed ID: 10524847
[TBL] [Abstract][Full Text] [Related]
7. [Cholangiocarcinoma with bile duct adenoma and hamartoma-like lesion in the bile duct].
Takahashi S; Takada K; Kawano Y; Miyanishi K; Ishiwatari H; Hayashi T; Sagawa T; Sato T; Sato Y; Takimoto R; Kobune M; Kuroiwa G; Hirayama M; Tobioka H; Hirata K; Omatsu M; Hasegawa T; Kato J
Nihon Shokakibyo Gakkai Zasshi; 2010 Mar; 107(3):461-9. PubMed ID: 20203450
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.
Hasebe T; Sakamoto M; Mukai K; Kawano N; Konishi M; Ryu M; Fukamachi S; Hirohashi S
Virchows Arch; 1995; 426(2):209-13. PubMed ID: 7757293
[TBL] [Abstract][Full Text] [Related]
9. Bile duct adenoma and von Meyenburg complex-like duct arising in hepatitis and cirrhosis: pathogenesis and histological characteristics.
Aishima S; Tanaka Y; Kubo Y; Shirabe K; Maehara Y; Oda Y
Pathol Int; 2014 Nov; 64(11):551-9. PubMed ID: 25329860
[TBL] [Abstract][Full Text] [Related]
10. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
Sano T; Yamamoto J; Kosuge T; Inoue K; Shimada K; Takayama T; Yamazaki S; Sakamoto M; Hirohashi S
Hepatogastroenterology; 1996; 43(9):667-70. PubMed ID: 8799413
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
Hornick JL; Lauwers GY; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
[TBL] [Abstract][Full Text] [Related]
14. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K
World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Tumor of the Hilar Bile Duct.
Umezaki N; Hashimoto D; Yamashita YI; Nakagawa S; Nakao Y; Itoyama R; Yusa T; Yamao T; Okabe H; Imai K; Hayashi H; Chikamoto A; Baba H
Anticancer Res; 2019 Feb; 39(2):903-907. PubMed ID: 30711974
[TBL] [Abstract][Full Text] [Related]
18. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
Yamamoto M; Takasaki K; Yoshikawa T; Ueno K; Nakano M
J Surg Oncol; 1998 Nov; 69(3):162-7. PubMed ID: 9846503
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma, 10-Year Survival After Liver Transplantation: A Case Report.
Herrero Torres MA; Dominguez Bastante M; Molina Raya A; Palomo Lopez I; Santoyo Villalba J; Villegas Herrera MT; Becerra Massare A; Brea Gomez E; Zambudio Carroll N; Villar Del Moral JM
Transplant Proc; 2020 Mar; 52(2):592-593. PubMed ID: 32057500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
